These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22872444)

  • 1. Molecular characteristics of fibrolamellar hepatocellular carcinoma.
    Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Törzsök P; Kovalszky I; Barbai T; Rásó E; Lotz G; Schaff Z; Kiss A
    Pathol Oncol Res; 2013 Jan; 19(1):63-70. PubMed ID: 22872444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudins and tricellulin in fibrolamellar hepatocellular carcinoma.
    Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Straub BK; Schirmacher P; Kovalszky I; Lotz G; Kiss A; Schaff Z
    Virchows Arch; 2011 Jun; 458(6):679-88. PubMed ID: 21503766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.
    Imai Y; Oda H; Arai M; Shimizu S; Nakatsuru Y; Inoue T; Ishikawa T
    Jpn J Cancer Res; 1996 Oct; 87(10):1056-62. PubMed ID: 8957064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique genomic profile of fibrolamellar hepatocellular carcinoma.
    Cornella H; Alsinet C; Sayols S; Zhang Z; Hao K; Cabellos L; Hoshida Y; Villanueva A; Thung S; Ward SC; Rodriguez-Carunchio L; Vila-Casadesús M; Imbeaud S; Lachenmayer A; Quaglia A; Nagorney DM; Minguez B; Carrilho F; Roberts LR; Waxman S; Mazzaferro V; Schwartz M; Esteller M; Heaton ND; Zucman-Rossi J; Llovet JM
    Gastroenterology; 2015 Apr; 148(4):806-18.e10. PubMed ID: 25557953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma.
    Sciarra A; Park YN; Sempoux C
    Hum Pathol; 2020 Feb; 96():48-55. PubMed ID: 31931021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
    Hirsch TZ; Negulescu A; Gupta B; Caruso S; Noblet B; Couchy G; Bayard Q; Meunier L; Morcrette G; Scoazec JY; Blanc JF; Amaddeo G; Nault JC; Bioulac-Sage P; Ziol M; Beaufrère A; Paradis V; Calderaro J; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2020 May; 72(5):924-936. PubMed ID: 31862487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
    Ward SC; Waxman S
    Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.
    Malouf GG; Job S; Paradis V; Fabre M; Brugières L; Saintigny P; Vescovo L; Belghiti J; Branchereau S; Faivre S; de Reyniès A; Raymond E
    Hepatology; 2014 Jun; 59(6):2228-37. PubMed ID: 24443104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.
    Abdul-Al HM; Wang G; Makhlouf HR; Goodman ZD
    Int J Surg Pathol; 2010 Oct; 18(5):313-8. PubMed ID: 20444731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hepatocellular and cholangiocellular carcinoma in a dog.
    Shiga A; Shirota K; Enomoto M
    J Vet Med Sci; 2001 Apr; 63(4):483-6. PubMed ID: 11346190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrolamellar carcinoma of the liver: a distinct entity within the hepatocellular tumors. A review.
    Vecchio FM
    Appl Pathol; 1988; 6(2):139-48. PubMed ID: 2839216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver.
    El Dika I; Bowman AS; Berger MF; Capanu M; Chou JF; Benayed R; Zehir A; Shia J; O'Reilly EM; Klimstra DS; Solit DB; Abou-Alfa GK
    Cancer; 2020 Sep; 126(18):4126-4135. PubMed ID: 32663328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.
    Dinh TA; Vitucci EC; Wauthier E; Graham RP; Pitman WA; Oikawa T; Chen M; Silva GO; Greene KG; Torbenson MS; Reid LM; Sethupathy P
    Sci Rep; 2017 Mar; 7():44653. PubMed ID: 28304380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
    Fu X; Tan L; Liu S; Li H; Chen L; Qin J; Wu M; Wang H
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):514-20. PubMed ID: 15221469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.
    Palm V; Sheng R; Mayer P; Weiss KH; Springfeld C; Mehrabi A; Longerich T; Berger AK; Kauczor HU; Weber TF
    Cancer Imaging; 2018 Mar; 18(1):9. PubMed ID: 29490696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization.
    Wilkens L; Bredt M; Flemming P; Kubicka S; Klempnauer J; Kreipe H
    Am J Clin Pathol; 2000 Dec; 114(6):867-74. PubMed ID: 11338475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA; Ahmed NS
    Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary liver carcinoma arising in people younger than 30 years.
    Klein WM; Molmenti EP; Colombani PM; Grover DS; Schwarz KB; Boitnott J; Torbenson MS
    Am J Clin Pathol; 2005 Oct; 124(4):512-8. PubMed ID: 16146811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
    Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
    Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features.
    Malouf GG; Tahara T; Paradis V; Fabre M; Guettier C; Yamazaki J; Long H; Lu Y; Raynal NJ; Jelinek J; Mouawad R; Khayat D; Brugières L; Raymond E; Issa JP
    Epigenetics; 2015; 10(9):872-81. PubMed ID: 26224146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.